Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas.

MLA

Krex, Dietmar, et al. “Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas.” International Journal of Molecular Sciences, vol. 24, no. 5, Mar. 2023, p. 5016. EBSCOhost, https://doi.org/10.3390/ijms24055016.

APA

Krex, D., Bartmann, P., Lachmann, D., Hagstotz, A., Jugel, W., Schneiderman, R. S., Gotlib, K., Porat, Y., Robel, K., Temme, A., Giladi, M., & Michen, S. (2023). Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas. International Journal of Molecular Sciences, 24(5), 5016. https://doi.org/10.3390/ijms24055016

Chicago

Krex, Dietmar, Paula Bartmann, Doris Lachmann, Alexander Hagstotz, Willi Jugel, Rosa S. Schneiderman, Karnit Gotlib, et al. 2023. “Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas.” International Journal of Molecular Sciences 24 (5): 5016. doi:10.3390/ijms24055016.